NCT02965027View on ClinicalTrials.gov

Prazosin for Post-Concussive Headaches

PHASE4CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

November 29, 2016

Primary Completion Date

May 9, 2023

Study Completion Date

June 7, 2023

Conditions
Post-Traumatic Headache
Interventions
DRUG

Prazosin

DRUG

Placebo

Trial Locations (2)

98108

VA Puget Sound Health Care System, Seattle

98433

Madigan Army Medical Center, Tacoma

All Listed Sponsors
collaborator

VA Puget Sound Health Care System

FED

collaborator

Madigan Army Medical Center

FED

lead

Seattle Institute for Biomedical and Clinical Research

OTHER

NCT02965027 - Prazosin for Post-Concussive Headaches | Biotech Hunter | Biotech Hunter